Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an announcement.
Kissei Pharmaceutical Co., Ltd. announced a change in the scheduled date for commencing dividend payments, moving it from December 3, 2025, to December 2, 2025. This adjustment is intended to readjust administrative procedures related to dividend payments, with no change to the dividend per share amount.
The most recent analyst rating on (JP:4547) stock is a Hold with a Yen5027.00 price target. To see the full list of analyst forecasts on Kissei Pharmaceutical Co stock, see the JP:4547 Stock Forecast page.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is led by Chairman and CEO Mutsuo Kanzawa.
YTD Price Performance: 16.03%
Average Trading Volume: 70,708
Technical Sentiment Signal: Buy
Current Market Cap: Yen191.8B
For an in-depth examination of 4547 stock, go to TipRanks’ Overview page.